Pediatrics Doctors in Thornton, CO Accepting Medicare

27 Pediatrics doctors found. Showing 21 - 27

Mrs. Gita Singh Sikand, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 9141 Grant St, #100, Thornton, CO 80229 Phone: 303-920-9000    Fax: 303-920-4000

Hannah Mae Evans-hamer, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2900 E 136th Ave Ste 201, Thornton, CO 80241 Phone: 303-996-6005    Fax: 303-420-8831

Yadira Caraveo, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2691 E 121st Pl, Thornton, CO 80241 Phone: 720-280-9405

Sheela Nancy Mahnke, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 9197 Grant St, Suite 200, Thornton, CO 80229 Phone: 303-450-3690    Fax: 303-450-3699

Dr. Georgie Kurian Philip, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3260 E 104th Ave, Thornton, CO 80233 Phone: 720-929-8300

Dr. Vera Becka, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3260 104th Ave., Thornton, CO 80233 Phone: 720-929-8300    Fax: 720-929-8444

Madison Mchenry Berglund, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 9197 Grant St Ste 100, Thornton, CO 80229 Phone: 303-450-3690    Fax: 303-962-1511

News Archive

New portable infectious disease detector

A portable device similar to today's home pregnancy tests that can quickly detect the presence of infectious diseases, including HIV-AIDS and measles, as well as biological agents such as ricin and anthrax, is the object of a new joint university/industry research project.

Lytix Biopharma, KAEL-GemVax granted approval for GV1001/LTX-315 combination cancer therapy study

The Norwegian biopharmaceutical company Lytix Biopharma and Korean company KAEL-GemVax today announced approval by the Norwegian Medicines Agency ('Statens Legemiddelverk') to test a combination of LTX-315 and GV1001 as vaccine therapy in patients with resected tumours. Lytix Biopharma CEO Gunnar Salid states, "We are delighted to announce the approval of our joint study to test a combination of two very interesting experimental drugs.

Discovery Lab enrolls first patient in phase 2a clinical trial of AEROSURF

Discovery Laboratories, Inc., a specialty biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today reported that the first patient has been enrolled in the next phase of its phase 2a clinical evaluation of AEROSURF, which is designed to evaluate the safety and tolerability of higher and repeat doses of aerosolized KL4 surfactant administered to premature infants 29 to 34 weeks gestational age (GA) who are receiving nasal continuous positive airway pressure (nCPAP) for respiratory distress syndrome (RDS), compared to infants receiving nCPAP alone.

Black cohosh does not reduce hot flashes in women

Mayo Clinic researchers, working with North Central Cancer Treatment Group (NCCTG) investigators, will present new study findings about treatments to reduce hot flashes in women. The research will be outlined during the 2005 American Society of Clinical Oncology (ASCO) Annual Meeting, May 13-17 in Orlando, Fla.

Read more Medical News

› Verified 2 days ago

• 1
• 2(current)